Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting on the role of the chronologically preceding agents, interferon-alfa and lamivudine. The impact of interferon-alfa on the incidence of HCC is clearer in Asian patients and those with compensated cirrhosis, as several meta-analyses have consistently shown HCC risk reduction, compared to untreated patients. Nucleos(t)ide analogues also seem to have a favorable impact on the HCC incidence when data from randomized or matched controlled studies are considered. Given that the high-genetic barrier agents, entecavir and tenofovir, are mainly used in CHB because of their favorable effects on the overall long-term outcome of such patients, the most clinically important challenge is the identification of patients who require close HCC surveillance despite on-therapy virological remission. Several risk scores have been developed for HCC prediction in CHB patients. Most of them, such as GAG-HCC, CU-HCC and REACH-B, have been developed and validated in Asian untreated and treated CHB patients, but they do not seem to offer good predictability in Caucasian CHB patients for whom a newer score, PAGE-B, has been recently developed.
Citations
Citations to this article as recorded by
Predictors of hepatic flares after nucleos(t)ide analogue cessation – Results of a global cohort study (RETRACT-B study) Edo J. Dongelmans, Grishma Hirode, Bettina E. Hansen, Chien-Hung Chen, Tung-Hung Su, Wai-Kay Seto, Arno Furquim d'Almeida, Stijn van Hees, Margarita Papatheodoridi, Sabela Lens, Grace L.H. Wong, Sylvia M. Brakenhoff, Rong-Nan Chien, Jordan J. Feld, Henry Journal of Hepatology.2025; 82(3): 446. CrossRef
Dynamic Profiles of Internal m7G Methylation on mRNAs in the Progression from HBV Infection to Hepatocellular Carcinoma Yunyue Xiao, Min Shi, Jiahong Xiao, Xiaojuan Xie, Ning Song, Minmin Li, Tao Guo, Wensheng Chen Digestive Diseases and Sciences.2025; 70(1): 245. CrossRef
A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis B Yeonjung Ha, Seungseok Lee, Jihye Lim, Kwanjoo Lee, Young Eun Chon, Joo Ho Lee, Kwan Sik Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Dong Keon Yon, Jinseok Lee, Han Chu Lee Liver International.2025;[Epub] CrossRef
Rationalising Hepatocellular Carcinoma Screening in Chronic Hepatitis B: Evaluation of Predictive Scores in an Australian Cohort Thisuri Jayawardena, Zein Salim, Luis Calzadilla Bertot, Joanne Bunney, Nicolas Demasi, Joanne Vallve, Leon Adams, Gary Jeffrey, David Speers, Gerry MacQuillan, Tim Mitchell Liver International.2025;[Epub] CrossRef
Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China Rong Fan, Ning Yu, Jimmy Che‐To Lai, Vicki Wing‐Ki Hui, Jie Peng, Yongpeng Chen, Zhihong Liu, Xieer Liang, Henry Lik‐Yuen Chan, Junhua Yin, Vincent Wai‐Sun Wong, Chunxiu Zhong, Grace Lai‐Hung Wong, Jian Sun, Terry Cheuk‐Fung Yip, Jinlin Hou Alimentary Pharmacology & Therapeutics.2025; 62(4): 419. CrossRef
Combining serologic biomarkers with the PAGE B score improves risk stratification for hepatocellular carcinoma development among chronic hepatitis B patients Michael Stec, Mark Anderson, Mary A. Rodgers, Tiffany Fortney, Danny Ka-Ho Wong, Lung-Yi Mak, Man-Fung Yuen, Gavin A. Cloherty Scientific Reports.2025;[Epub] CrossRef
Chronic hepatitis B: Is it time for expanded antiviral treatment? Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra World Journal of Virology.2025;[Epub] CrossRef
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER) Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, Marc Bourliere, Shaowen Jiang, Nathalie Ganne-Carrie, Willem-Pieter Brouwer, Jordan J Feld, Yuxian Huang, Jose A Carrion, Teresa Broquetas, Qiankun Hu, Scott Fung, Fabrice Carrat, Fabien Zoulim, Bettina E Gut.2025; : gutjnl-2025-336251. CrossRef
Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysis An Tu, Xiaoning Zhu, Paniz Zarghami Dastjerdi, Yue Yin, Mengyun Peng, Ding Zheng, Zhaoxuan Peng, Encheng Wang, Xiaodong Wang, Wang Jing Heliyon.2024; 10(3): e24437. CrossRef
Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B Ploutarchos Pastras, Evaggelos Zazas, Maria Kalafateli, Ioanna Aggeletopoulou, Efthymios P. Tsounis, Stavros Kanaloupitis, Konstantinos Zisimopoulos, Eirini-Eleni-Konstantina Kottaridou, Aspasia Antonopoulou, Dimosthenis Drakopoulos, Georgia Diamantopoulo Cancers.2024; 16(14): 2521. CrossRef
Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan Kai‐Chi Chang, Mei‐Hwei Chang, Huey‐Ling Chen, Fang‐Wen Cheng, Jia‐Feng Wu, Wei‐Ju Su, Hong‐Yuan Hsu, Yen‐Hsuan Ni Liver International.2024; 44(8): 2054. CrossRef
Risk Factors and Comorbidities Associated With Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Helen Weidemann, Kristen Yeh, Krystal Hunter, Satyajeet Roy Journal of Primary Care & Community Health.2024;[Epub] CrossRef
Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma Gupse Adali, Huseyin Aykut, Nermin Mutlu Bilgic, Yusuf Yilmaz Heliyon.2024; 10(18): e37990. CrossRef
Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B Yusuf Emre Ozdemir, Meryem Sahin Ozdemir, Osman Faruk Bayramlar, Serkan Surme, Sibel Yildiz Kaya, Ridvan Karaali, Ilker Inanc Balkan, Bilgul Mete, Nese Saltoglu, Fehmi Tabak Irish Journal of Medical Science (1971 -).2023; 192(2): 633. CrossRef
A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus Grace X. Ma, Lin Zhu, Yin Tan, Shumenghui Zhai, Xiaoli Ma, Olorunseun O. Ogunwobi, Wei Jenny Yang, Tsunyou Ting, Sara Kim, Min Qi Wang Digestive Diseases and Sciences.2023; 68(6): 2333. CrossRef
Racial and Ethnic Disparities in Characteristics and Care Patterns of Chronic Hepatitis B Patients in the United States Joanne K. Liu, Leslie Y. Kam, Daniel Q. Huang, Linda Henry, Ramsey Cheung, Mindie H. Nguyen Clinical Gastroenterology and Hepatology.2023; 21(10): 2606. CrossRef
Hepatitis B and C: neglected infectious diseases among Syrian refugees in Lebanon Layal Al Mahmasani, Umayya Musharrafieh, Zeina Bayram, Abdul Rahman Bizri Journal of Global Health Reports.2023;[Epub] CrossRef
Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysis Piyameth Dilokthornsakul, Ratree Sawangjit, Pisit Tangkijvanich, Maneerat Chayanupatkul, Pajaree Sriuttha, Unchalee Permsuwan Expert Review of Pharmacoeconomics & Outcomes Research.2023; 23(8): 951. CrossRef
Test All for Hepatitis B Virus Katerina Roma, Zahra Dossaji, Lubaba Haque, Tooba Laeeq, Robert G. Gish, Carol Brosgart Clinics in Liver Disease.2023; 27(4): 997. CrossRef
Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy Chih-Lang Lin, Szu-Yuan Wu, Ming-Wei Lai, Chao-Wei Hsu, Wan-Ming Chen, An-Tzu Jao, Cheng-Hung Chien, Ching-Chih Hu, Rong-Nan Chien, Chau-Ting Yeh Cancers.2023; 15(13): 3343. CrossRef
The Different Prognoses of Hepatocellular Carcinoma with Previous Tenofovir versus Entecavir Treatment for Chronic Hepatitis B Virus: Analysis Based on 15 Propensity Score-Matched Studies Jiancun Hou, Zhe Qiang, Yang Li, Yamin Zhang Digestive Diseases.2023; 41(3): 476. CrossRef
Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon Clinical and Molecular Hepatology.2023; 29(4): 1029. CrossRef
Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma Soo Ryang Kim, Soo Ki Kim Diagnostics.2023; 13(20): 3212. CrossRef
State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection Peter Schemmer, Patrizia Burra, Rey‐Heng Hu, Christian M. Hüber, Carmelo Loinaz, Keigo Machida, Arndt Vogel, Didier Samuel Liver International.2022; 42(2): 288. CrossRef
Therapeutic Advances in Viral Hepatitis A–E Navroop Nagra, Richard A. Kozarek, Blaire E. Burman Advances in Therapy.2022; 39(4): 1524. CrossRef
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases Maria Stella Franzè, Teresa Pollicino, Giovanni Raimondo, Giovanni Squadrito Liver International.2022; 42(5): 963. CrossRef
Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992–2018 Christian S. Alvarez, Jessica L. Petrick, Dominick Parisi, Brian J. McMahon, Barry I. Graubard, Katherine A. McGlynn Hepatology.2022; 76(3): 589. CrossRef
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani World Journal of Gastroenterology.2022; 28(21): 2251. CrossRef
Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus Darren Jun Hao Tan, Cheng Han Ng, Phoebe Wen Lin Tay, Nicholas Syn, Mark D. Muthiah, Wen Hui Lim, Ansel Shao Pin Tang, Kai En Lim, Grace En Hui Lim, Nobuharu Tamaki, Beom Kyung Kim, Margaret Li Peng Teng, James Fung, Rohit Loomba, Mindie H. Nguyen, Daniel JAMA Network Open.2022; 5(6): e2219407. CrossRef
Changes in the Epidemiology of Hepatocellular Carcinoma in Asia Yao Liu, Lianxin Liu Cancers.2022; 14(18): 4473. CrossRef
Improving Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic Hepatitis B (CHB) through a Multicomponent Culturally Tailored Intervention: A Randomized Controlled Trial Grace X. Ma, Lin Zhu, Wenyue Lu, Elizabeth Handorf, Yin Tan, Ming-Chin Yeh, Cicely Johnson, Guercie Guerrier, Minhhuyen T. Nguyen Healthcare.2022; 10(10): 1944. CrossRef
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review Chan Keat Kang, Paul N Brennan, John F Dillon Clinical Interventions in Aging.2022; Volume 17: 1811. CrossRef
Assessing the Effectiveness of Traditional Chinese Medicine as Neoadjuvant Therapy for Lowering Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Induced Cirrhosis: A Systematic Review and Meta-Analysis Samuel Okoye, Chinedu Obi, Ibrahim Musa Interdisciplinary Research in Medical Sciences Specialty.2022; 2(2): 48. CrossRef
Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir Jung Woo Shin, Joonho Jeong, Seok Won Jung, Seung Bum Lee, Bo Ryung Park, Min-Ju Kim, Eun Ji Park, Neung Hwa Park Digestive Diseases and Sciences.2021; 66(5): 1739. CrossRef
Addition of liver stiffness enhances the predictive accuracy of the PAGE‐B model for hepatitis B‐related hepatocellular carcinoma Hye Yeon Chon, Han Ah Lee, Sang Jun Suh, Jung Il Lee, Byung Seok Kim, In Hee Kim, Chang Hyeong Lee, Byoung Kuk Jang, Hyun Woong Lee, Jae Seok Hwang, Chang Hun Lee, Jin‐Woo Lee, Jung Hwan Yu, Yeon Seok Seo, Hyung Joon Yim, Seung Up Kim Alimentary Pharmacology & Therapeutics.2021; 53(8): 919. CrossRef
Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study Jayoun Lee, Gi‐Ae Kim, Hyo Jeong Kim, Songhee Cho, Min Jung Ko, Young‐Suk Lim Journal of Viral Hepatitis.2021; 28(8): 1150. CrossRef
Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy Maria Buti, Mar Riveiro-Barciela, Rafael Esteban Clinics in Liver Disease.2021; 25(4): 725. CrossRef
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik Hepatology International.2021; 15(4): 892. CrossRef
Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence Yuanyuan Liu, Vaishnavi Veeraraghavan, Monica Pinkerton, Jianjun Fu, Mark W. Douglas, Jacob George, Thomas Tu Frontiers in Microbiology.2021;[Epub] CrossRef
Maternal Hepatitis B or Hepatitis C Virus Carrier Status is Not a Risk Factor for Long-Term Oncologic Morbidity of the Offspring: A Population-Based Cohort Study Naim Abu-Freha, Tamar Wainstock, Liat Poupko, Eyal Sheiner Cancer Investigation.2021; 39(9): 690. CrossRef
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim Clinical and Molecular Hepatology.2021; 27(2): 295. CrossRef
Controversies in the Management of Hepatitis B Stuart K. Roberts, Ammar Majeed, William Kemp Clinics in Liver Disease.2021; 25(4): 785. CrossRef
Hepatitis B Before and After Hepatocellular Carcinoma Murat Harputluoglu, Brian I. Carr Journal of Gastrointestinal Cancer.2021; 52(4): 1206. CrossRef
SASLT practice guidelines for the management of Hepatitis B virus – An update Faisal A. Abaalkhail, Waleed K. Al-Hamoudi, Abdullah Khathlan, Saad Alghamdi, Mohammed Alghamdi, Saleh A. Alqahtani, Faisal M. Sanai Saudi Journal of Gastroenterology.2021; 27(3): 115. CrossRef
Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy Mi Na Kim, Ju Ho Lee, Young Eun Chon, Yeonjung Ha, Seong Gyu Hwang European Journal of Gastroenterology & Hepatology.2020; 32(3): 433. CrossRef
BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA Aline Lopes CHAGAS, Angelo Alves de MATTOS, Flair José CARRILHO, Paulo Lisboa BITTENCOURT, Denise Cerqueira Paranaguá VEZOZZO, Natally HORVAT, Manoel de Souza ROCHA, Venâncio Avancini Ferreira ALVES, Gabriela Perdomo CORAL, Mario Reis ALVARES-DA-SILVA, Fa Arquivos de Gastroenterologia.2020; 57(suppl 1): 1. CrossRef
Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma Mi Young Jeon, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Seung Up Kim Journal of Viral Hepatitis.2020; 27(9): 932. CrossRef
Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels Lingmei Wang, Jiao Li, Kai Yang, Hao Zhang, Qin Wang, Xiongwen Lv, Shihe Guan Medicine.2020; 99(23): e20548. CrossRef
Carcinoma hepatocelular L. Márquez Pérez, S. Alonso López, J.L. Herrera Fajes, L. Carrión Martín Medicine - Programa de Formación Médica Continuada Acreditado.2020; 13(12): 653. CrossRef
Documento de consenso de la Asociación Española para el Estudio del Hígado sobre el tratamiento de la infección por el virus de la hepatitis B (2020) Manuel Rodríguez, María Buti, Rafael Esteban, Sabela Lens, Martín Prieto, Emilio Suárez, Javier García-Samaniego Gastroenterología y Hepatología.2020; 43(9): 559. CrossRef
Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma Lung-Yi Mak, Kwan-Lung Ko, Wai-Pan To, Danny Ka-Ho Wong, Wai-Kay Seto, James Fung, Man-Fung Yuen Gut and Liver.2020; 14(5): 665. CrossRef
Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma SalehA Alqahtani, FaisalM Sanai, Ashwaq Alolayan, Faisal Abaalkhail, Hamad Alsuhaibani, Mazen Hassanain, Waleed Alhazzani, Abdullah Alsuhaibani, Abdullah Algarni, Alejandro Forner, RichardS Finn, WaleedK Al-hamoudi Saudi Journal of Gastroenterology.2020; 26(7): 1. CrossRef
Comparison of the on‐treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis Ingyoon Ha, Jung Wha Chung, Eun Sun Jang, Sook‐Hyang Jeong, Jin‐Wook Kim Journal of Gastroenterology and Hepatology.2020; 35(10): 1774. CrossRef
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel World Journal of Gastroenterology.2020; 26(38): 5759. CrossRef
Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020) Manuel Rodríguez, María Buti, Rafael Esteban, Sabela Lens, Martín Prieto, Emilio Suárez, Javier García-Samaniego Gastroenterología y Hepatología (English Edition).2020; 43(9): 559. CrossRef
Serum Mac‐2‐binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir‐treated chronic hepatitis B patients Lung‐Yi Mak, Michael Ko, Elvis To, Danny Ka‐Ho Wong, Justin Hei‐Chun Ma, Teresa Lok‐Yee Hui, Wai‐Kay Seto, James Fung, Ching‐Lung Lai, Man‐Fung Yuen Journal of Gastroenterology and Hepatology.2019; 34(10): 1817. CrossRef
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B Jonggi Choi, Hyo Jeong Kim, Jayoun Lee, Songhee Cho, Min Jung Ko, Young-Suk Lim JAMA Oncology.2019; 5(1): 30. CrossRef
Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients Lung-Yi Mak, Wai-Pan To, Danny Ka-Ho Wong, James Fung, Fen Liu, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen World Journal of Gastroenterology.2019; 25(11): 1398. CrossRef
Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013 Meredith S. Shiels, Eric A. Engels, Elizabeth L. Yanik, Katherine A. McGlynn, Ruth M. Pfeiffer, Thomas R. O’Brien Cancer.2019; 125(15): 2621. CrossRef
Infection par le virus de l’hépatite B : histoire naturelle, manifestations cliniques et principes thérapeutiques O. Paccoud, L. Surgers, K. Lacombe La Revue de Médecine Interne.2019; 40(9): 590. CrossRef
Updates on Chronic HBV: Current Challenges and Future Goals Hannah M. Lee, Bubu A. Banini Current Treatment Options in Gastroenterology.2019; 17(2): 271. CrossRef
High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, Seungbong Han, Young‐Suk Lim Alimentary Pharmacology & Therapeutics.2019; 50(2): 215. CrossRef
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis Tung-Hung Su, Cheng-Yuan Peng, Tai-Chung Tseng, Hung-Chih Yang, Chun-Jen Liu, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao The Journal of Infectious Diseases.2019;[Epub] CrossRef
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B Shan Shan, Hong You, Junqi Niu, Jia Shang, Wen Xie, Yuexin Zhang, Xun Li, Hong Ren, Hong Tang, Huiguo Ding, Xihong Wang, Yuemin Nan, Xiaoguang Dou, Tao Han, Lingyi Zhang, Xiaoqing Liu, Cunliang Deng, Jilin Cheng, Xiaozhong Wang, Qing Xie, Shumei Lin, Yan Journal of Clinical and Translational Hepatology.2019; X(X): 1. CrossRef
Aspartate transaminase to platelet ratio index and gamma‐glutamyl transpeptidase‐to‐platelet ratio outweigh fibrosis index based on four factors and red cell distribution width‐platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepati Xiaojuan Wu, Bei Cai, Zhenzhen Su, Yamei Li, Jin Xu, Rong Deng, Lanlan Wang Journal of Clinical Laboratory Analysis.2018;[Epub] CrossRef
Practical guidelines for performing laparoscopic liver resection based on the second international laparoscopic liver consensus conference Jai Young Cho, Ho-Seong Han, Go Wakabayashi, Olivier Soubrane, David Geller, Nicholas O'Rourke, Joseph Buell, Daniel Cherqui Surgical Oncology.2018; 27(1): A5. CrossRef
Clinical states of cirrhosis and competing risks Gennaro D'Amico, Alberto Morabito, Mario D'Amico, Linda Pasta, Giuseppe Malizia, Paola Rebora, Maria Grazia Valsecchi Journal of Hepatology.2018; 68(3): 563. CrossRef
Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyon-Suk Kim, Young Nyun Park, Kwang-Hyub Han, Kijun Song, Seung Up Kim Gut and Liver.2018; 12(2): 190. CrossRef
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee Gut.2018; 67(5): 945. CrossRef
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher, Valérie Vilgrain Journal of Hepatology.2018; 69(1): 182. CrossRef
Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients? Elia Moreno-Cubero, Robert T Sánchez del Arco, Julia Peña-Asensio, Eduardo Sanz de Villalobos, Joaquín Míquel, Juan Ramón Larrubia World Journal of Gastroenterology.2018; 24(17): 1825. CrossRef
Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir Jung Woo Shin, Seok Won Jung, Seung Bum Lee, Byung Uk Lee, Bo Ryung Park, Eun Ji Park, Neung Hwa Park American Journal of Gastroenterology.2018; 113(7): 998. CrossRef
Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang American Society of Clinical Oncology Educational Book.2018; (38): 262. CrossRef
Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment Nam Hee Kim, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim Digestive Diseases and Sciences.2018; 63(10): 2792. CrossRef
A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir Hung‐Hsien Chiang, Chuan‐Mo Lee, Tsung‐Hui Hu, Chao‐Hung Hung, Jing‐Houng Wang, Sheng‐Nan Lu, Hsueh‐Chou Lai, Wen‐Pang Su, Chia‐Hsin Lin, Cheng‐Yuan Peng, Chien‐Hung Chen Liver International.2018; 38(11): 1997. CrossRef
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy Byeong G. Song, Dong H. Sinn, Sangah Chi, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik European Journal of Gastroenterology & Hepatology.2018; 30(12): 1447. CrossRef
Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients? Sung Won Chung, Young Chang, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim Gastroenterology Research and Practice.2018; 2018: 1. CrossRef
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke Journal of Hepatology.2017; 67(2): 370. CrossRef
Detection of HBV Covalently Closed Circular DNA Xiaoling Li, Jinghua Zhao, Quan Yuan, Ningshao Xia Viruses.2017; 9(6): 139. CrossRef
Gamma‐glutamyl transpeptidase‐to‐platelet ratio is an independent predictor of hepatitis B virus‐related liver cancer Yong Eun Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Sojung Han, Mi Young Jeon, Ja Yoon Heo, Kijun Song, Seung Up Kim Journal of Gastroenterology and Hepatology.2017; 32(6): 1221. CrossRef
Effect of modified Xiaochaihu decoction-containing serum on HepG2.2.15 cells via the JAK2/STAT3 signaling pathway Shaofang Chen, Zhanglin Wang, Shichuan Wan, Hai Huang, Huiqing Liang Molecular Medicine Reports.2017; 16(5): 7416. CrossRef
First
Prev
